
Painkiller IS WOKE!
SHOW TYPE
TV
SHOW LENGTH
45 min
PROTECTION
TV-MA
RELEASED
2023
The causes and consequences of America's opioid epidemic unfold in this drama following its perpetrators, victims and an investigator seeking the truth.
Painkiller exposes the roots of the most pressing health epidemic of the 21st century. Powerful narcotic painkillers, or opioids, were once used as drugs of last resort for pain sufferers. Purdue turned OxyContin into a billion dollar blockbuster by launching an unprecedented marketing campaign claiming that the drug's long-acting formulation made it safer to use than traditional painkillers for many types of pain.
That illusion was quickly shattered as drug abusers learned that crushing an Oxy could release its narcotic payload all at once. Even in its prescribed form, Oxy proved fiercely addictive. As OxyContin's use and abuse grew, Purdue concealed what it knew from regulators, doctors, and patients.
WHAT CRITERIA MAKES IT WOKE?
WOKE EVIDENCE:
- The women claim oppression by men.
- Rich white men cause these type of issues.
0 · Ranked 0. Needs +4 to keep this title omitted (4 more net +1).- The women claim oppression by men.
- Rich white men cause these type of issues.
0 · Ranked 0. Needs +4 to keep this title omitted (4 more net +1).
Community verdict · separate from the catalog
No community verdict yet · Not in the catalog
Community verdict: woke. Not in the catalog. 100% labeled it woke, and a justification is ranked at 0 (needs +5 to keep it out).
0 of 1 did not label it woke · 1 did (100%) · top reason 0 / +5 · 5 members to decide
Report a mistake
Same rule as woke labels: one report, a written reason, and the community +1 or −1 it — once per member. A net +5 applies the change. Editors can also apply it immediately.
No mistake reports yet.
Sign in to report a mistake. One report per field, per member.
Why members pulled it
This title is not in the catalog. Each label is a published criterion plus written evidence. +1 or −1 the argument — once.

Comments and reviews
No comments or reviews yet.